Buscar
Congreso SOLACI
HomeInternational CongresseseuroPCR 2013 .

euroPCR 2013 .

Ver Categoría
Day 2

DEFLECT I: cerebral protection device in TAVI

Strokes after TAVI occur in between 3.8 and 6.7% of the cases, with new MRI lesions being...
solaci -
Ver más
Day 2

DIRECT: results of drug-eluting stent-on-a-wire after 6 months

This balloon expandable stent is combined with a guide 0.014 in its distal part. The platform is...
solaci -
Ver más
Day 2

POLAR ACS: bio-absorbable platform in acute coronary syndromes

Bio-absorbable devices are considered safe and effective for stable patients but there is still little information regarding...
solaci -
Ver más
Day 2

PRAGUE 19: bioabsorbable platform for patients with ST segment elevation

Absorbable bioplatforms are considered safe and effective in stable patients but their use in the context of...
solaci -
Ver más
Day 2

HATTRICK-OCT: biodegradable polymer struts coverage versus permanent

Late endothelialization of first generation pharmacological stents may predispose thrombosis. Both the drug and the polymer of...
solaci -
Ver más
Day 2

PROMUS PREMIER: new everolimus-eluting stent

The study aims to evaluate clinical, angiographic and IVUS results of the new platinum chromium everolimus stent....
solaci -
Ver más
Day 1

SOURCE XT: Results of the latest generation of the Edwards valve

The first generation of the Edwards valve was stainless steel and bovine pericardium with a profile of...
solaci -
Ver más
Day 2

CENTURY: new clinical results of sirolimus-eluting degradable polymer stent

This new stent is a sirolimus-eluting low-profile cobalt chrome platform (80 µm) with a rapid resorption polymer...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

Dr. Omar Tupayachi - 0
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Dr. Andrés Rodríguez - 0
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Dr. Omar Tupayachi - 0
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Noticias Institucionales

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

solaci - 0
Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad